- Home
- NXXT vs HQL Comparison
NXXT vs HQL Comparison
Compare NXXT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXXT
- HQL
- Stock Information
- Founded
- NXXT 2019
- HQL 1992
- Country
- NXXT United States
- HQL United States
- Employees
- NXXT N/A
- HQL N/A
- Industry
- NXXT
- HQL Investment Managers
- Sector
- NXXT
- HQL Finance
- Exchange
- NXXT NYSE
- HQL Nasdaq
- Market Cap
- NXXT 390.9M
- HQL 368.7M
- IPO Year
- NXXT N/A
- HQL N/A
- Fundamental
- Price
- NXXT $3.06
- HQL $12.12
- Analyst Decision
- NXXT
- HQL
- Analyst Count
- NXXT 0
- HQL 0
- Target Price
- NXXT N/A
- HQL N/A
- AVG Volume (30 Days)
- NXXT 47.9K
- HQL 120.9K
- Earning Date
- NXXT 05-23-2025
- HQL 01-01-0001
- Dividend Yield
- NXXT N/A
- HQL 11.56%
- EPS Growth
- NXXT N/A
- HQL N/A
- EPS
- NXXT N/A
- HQL 0.79
- Revenue
- NXXT $27,770,279.00
- HQL N/A
- Revenue This Year
- NXXT N/A
- HQL N/A
- Revenue Next Year
- NXXT N/A
- HQL N/A
- P/E Ratio
- NXXT N/A
- HQL $17.08
- Revenue Growth
- NXXT 19.61
- HQL N/A
- 52 Week Low
- NXXT $2.19
- HQL $11.34
- 52 Week High
- NXXT $7.55
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- NXXT N/A
- HQL 46.08
- Support Level
- NXXT N/A
- HQL $11.88
- Resistance Level
- NXXT N/A
- HQL $12.53
- Average True Range (ATR)
- NXXT 0.00
- HQL 0.29
- MACD
- NXXT 0.00
- HQL -0.02
- Stochastic Oscillator
- NXXT 0.00
- HQL 19.83
About NXXT NEXTNRG INC
NextNRG Inc is engaged in developing an integrated ecosystem that combines solar energy generation, battery storage, smart microgrids, wireless electric vehicle (EV) charging, and on-demand fuel delivery. The company is also focused on combining renewable energy innovation with mobile fueling expertise to build a sustainable energy ecosystem that bridges traditional fuel needs with AI-powered clean energy solutions.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.